On the public citation graph
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA–peptide tetramers
0 signed · 483 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1016/s0140-6736(02)09672-1openalex-snapshot
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells
inferredcites →https://doi.org/10.1016/s0140-6736(03)14634-xopenalex-snapshot
Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines
inferredcites →https://doi.org/10.1038/nm0596-551openalex-snapshot
Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes
inferredcites →https://doi.org/10.1038/nm0898-975openalex-snapshot
T-cell epitope mapping by flow cytometry
inferredcites →https://doi.org/10.1046/j.1365-2141.2001.03106.xopenalex-snapshot
Purification of cytomegalovirus‐specific CD8 T cells from peripheral blood using HLA–peptide tetramers
inferredcites →https://doi.org/10.1056/nejm199404283301703openalex-snapshot
Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation
inferredcites →https://doi.org/10.1056/nejm199510193331603openalex-snapshot
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
inferredcites →https://doi.org/10.1080/146532401753174034openalex-snapshot
Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM–CAMPATH (± fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion
inferredcites →https://doi.org/10.1097/00007890-199707150-00020openalex-snapshot
PLASMA POLYMERASE CHAIN REACTION FOR CYTOMEGALOVIRUS DNA AFTER ALLOGENEIC MARROW TRANSPLANTATION
inferredcites →https://doi.org/10.1126/science.1352912openalex-snapshot
Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones
inferredcites →https://doi.org/10.1126/science.274.5284.94openalex-snapshot
Phenotypic Analysis of Antigen-Specific T Lymphocytes
inferredcites →https://doi.org/10.1128/jvi.74.17.8140-8150.2000openalex-snapshot
Functional Heterogeneity and High Frequencies of Cytomegalovirus-Specific CD8+T Lymphocytes in Healthy Seropositive Donors
inferredcites →https://doi.org/10.1182/blood.v97.4.994openalex-snapshot
Induction of cytomegalovirus (CMV)–specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions
inferredcites →https://doi.org/10.1182/blood.v97.5.1232openalex-snapshot
Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation
inferredcites →https://doi.org/10.1182/blood.v98.3.505openalex-snapshot
Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers
inferredcites →https://doi.org/10.1182/blood.v98.5.1358openalex-snapshot
Tetramer-based quantification of cytomegalovirus (CMV)–specific CD8+ T lymphocytes in T-cell–depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection
inferredcites →https://doi.org/10.1182/blood.v99.11.3916openalex-snapshot
Infusion of cytomegalovirus (CMV)–specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy
inferredcites →https://doi.org/10.1182/blood.v99.3.1071openalex-snapshot
Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen
inferredcites →https://doi.org/10.2144/98252st05openalex-snapshot
Detection and Characterization of αβ-T-Cell Clonality by Denaturing Gradient Gel Electrophoresis (DGGE)
inferredcites →https://doi.org/10.4049/jimmunol.162.3.1827openalex-snapshot
A Re-Evaluation of the Frequency of CD8+ T Cells Specific for EBV in Healthy Virus Carriers
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3904656openalex-extracted
Comparison of Transplant Donor- and Third-Party Donor-Derived CMV-Specific T Cells for CMV Infection After Allogenic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1002/9781118416426.ch15openalex-snapshot
Immune Reconstitution Following Hematopoietic Cell Transplantation
inferred← citeshttps://doi.org/10.1002/9781118416426.ch68openalex-snapshot
Adoptive T‐cell Therapy for Viral Disease in the Setting of Hematopoietic Cell Transplantation
inferred← citeshttps://doi.org/10.1002/9781118520093.ch43openalex-snapshot
Recent Advances in Clinical Cellular Immunotherapy
inferred← citeshttps://doi.org/10.1002/9781119129431.ch43openalex-snapshot
Recent Advances in Clinical Cellular Immunotherapy
inferred← citeshttps://doi.org/10.1002/9781119665885.ch45openalex-snapshot
CAR‐T Cells and Recent Advances in Clinical Cellular Immunotherapy
inferred← citeshttps://doi.org/10.1002/acg2.86openalex-snapshot
Toward “off‐the‐shelf” allogeneic CAR T cells
inferred← citeshttps://doi.org/10.1002/ajh.26579openalex-snapshot
EBV ‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk‐stratification, and management
inferred← citeshttps://doi.org/10.1002/ajh.26824openalex-snapshot
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus‐specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis
inferred← citeshttps://doi.org/10.1002/ajh.27430openalex-snapshot
EBV ‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk‐stratification, and management
inferred← citeshttps://doi.org/10.1002/bit.21912openalex-snapshot
Magnetic cell separation using nano‐sized bacterial magnetic particles with reconstructed magnetosome membrane
inferred← citeshttps://doi.org/10.1002/cpdd.792openalex-snapshot
Pharmacokinetics and Immunogenicity of ASP0113 in CMV‐Seronegative Dialysis Patients and CMV‐Seronegative and ‐Seropositive Healthy Subjects
inferred← citeshttps://doi.org/10.1002/cyto.a.23146openalex-snapshot
Enumeration of WT1‐specific CD8+ T cells for clinical application using an MHC S treptamer based no‐wash single‐platform flow‐cytometric assay
inferred← citeshttps://doi.org/10.1002/eji.200939508openalex-snapshot
NK cells protect secondary lymphoid tissue from cytomegalovirus via a CD30‐dependent mechanism
inferred← citeshttps://doi.org/10.1002/eji.201242439openalex-snapshot
Specific CD 8+ T cells recognize human herpesvirus 6 B
inferred← citeshttps://doi.org/10.1002/eji.201242666openalex-snapshot
Strong and sustained effector function of memory‐ versus naïve‐derived T cells upon T ‐cell receptor RNA transfer: Implications for cellular therapy
inferred← citeshttps://doi.org/10.1002/eji.201545849openalex-snapshot
Antigen‐specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/eji.201747399openalex-snapshot
PRAME peptide‐specific CD8+ T cells represent the predominant response against leukemia‐associated antigens in healthy individuals
inferred← citeshttps://doi.org/10.1002/iid3.55openalex-snapshot
Identification of novel CD8+ T cell epitopes in human herpesvirus 6B U11 and U90
inferred← citeshttps://doi.org/10.1002/ijc.29190openalex-snapshot
T cell‐based targeted immunotherapies for patients with multiple myeloma
inferred← citeshttps://doi.org/10.1002/ijc.29909openalex-snapshot
Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation
inferred← citeshttps://doi.org/10.1002/rmv.2558openalex-snapshot
Efficacy and safety of adoptive T‐cell therapy in treating cytomegalovirus infections post‐haematopoietic stem cell transplantation: A systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1002/rmv.70135openalex-snapshot
Human Cytomegalovirus Infection in Haematopoietic Stem Cell Transplant Recipients and CAR‐T Cell Recipients— PART 2: Antiviral Therapy and Virus‐Specific T Cell Therapy for HCMV in Allo‐HSCT
inferred← citeshttps://doi.org/10.1002/stem.689openalex-snapshot
Concise Review: Expanding Roles for Hematopoietic Cellular Therapy and the Blood Transfusion Services
inferred← citeshttps://doi.org/10.1007/82_2025_296openalex-snapshot
The Role of EBV in the Pathogenesis of Diffuse Large B-Cell Lymphoma
inferred← citeshttps://doi.org/10.1007/978-0-387-78580-6_6openalex-snapshot
Clinical Implications of Immune Reconstitution Following Hematopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1007/978-1-4020-9063-9_72openalex-snapshot
Interleukin -7 and Immunorejuvenation
inferred← citeshttps://doi.org/10.1007/978-1-4419-7219-4_7openalex-snapshot
Clinical Applications of Activated Immune Cells
inferred← citeshttps://doi.org/10.1007/978-1-59745-450-6_28openalex-snapshot
High-Throughput T-Cell Epitope Discovery Through MHC Peptide Exchange
inferred← citeshttps://doi.org/10.1007/978-1-60761-461-6_15openalex-snapshot
Identifying Homing Interactions in T-Cell Traffic in Human Disease
inferred← citeshttps://doi.org/10.1007/978-1-60761-980-2_1openalex-snapshot
Extending the Use of Adoptive T Cell Immunotherapy for Infections and Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-53626-8_55openalex-snapshot
T-Cell Therapeutics: Donor Lymphocyte Infusion, Cytotoxic T-Lymphocyte Infusion, and Other Non-CAR T-Cell Therapies
inferred← citeshttps://doi.org/10.1007/978-3-0346-0219-8_9openalex-snapshot
Immunosenescence and the 3Rs: Restoration, Replacement and Reprogramming
inferred← citeshttps://doi.org/10.1007/978-3-319-54368-0_8openalex-snapshot
Cytotoxic T Cells for Infections: From Donor Specific to “Off the Shelf”
inferred← citeshttps://doi.org/10.1007/978-3-319-64597-1_72-1openalex-snapshot
Interleukin-7 and Immunorejuvenation
inferred← citeshttps://doi.org/10.1007/978-3-319-77674-3_20openalex-snapshot
Specific Adoptive T-Cell Therapy for Viral and Fungal Infections
inferred← citeshttps://doi.org/10.1007/978-3-319-99375-1_72openalex-snapshot
Interleukin-7 and Immunorejuvenation
inferred← citeshttps://doi.org/10.1007/978-90-481-3999-6_15openalex-snapshot
Maintenance and Restoration of Immune System Function
inferred← citeshttps://doi.org/10.1007/s00018-013-1463-5openalex-snapshot
Impact of T cell selection methods in the success of clinical adoptive immunotherapy
inferred← citeshttps://doi.org/10.1007/s00018-015-1986-zopenalex-snapshot
The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients
inferred← citeshttps://doi.org/10.1007/s00210-026-05853-1openalex-snapshot
Mechanistic insights into andrographolide-mediated cardioprotective action through mitochondrial homeostasis: a network pharmacology and in vivo approach
inferred← citeshttps://doi.org/10.1007/s00262-008-0480-yopenalex-snapshot
Cancer treatment: the combination of vaccination with other therapies
inferred← citeshttps://doi.org/10.1007/s00262-008-0578-2openalex-snapshot
A fast and efficient HLA multimer-based sorting procedure that induces little apoptosis to isolate clinical grade human tumor specific T lymphocytes
inferred← citeshttps://doi.org/10.1007/s00262-009-0722-7openalex-snapshot
The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.1007/s00262-009-0778-4openalex-snapshot
Multimer technologies for detection and adoptive transfer of antigen-specific T cells
inferred← citeshttps://doi.org/10.1007/s00262-009-0789-1openalex-snapshot
A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation
inferred← citeshttps://doi.org/10.1007/s00262-019-02395-9openalex-snapshot
T cell engineering for adoptive T cell therapy: safety and receptor avidity
inferred← citeshttps://doi.org/10.1007/s00281-008-0132-5openalex-snapshot
Reconstitution of the immune system after hematopoietic stem cell transplantation in humans
inferred← citeshttps://doi.org/10.1007/s00415-021-10952-5openalex-snapshot
Innovative therapeutic concepts of progressive multifocal leukoencephalopathy
inferred← citeshttps://doi.org/10.1007/s00430-008-0085-2openalex-snapshot
Refinement of strategies for the development of a human cytomegalovirus dense body vaccine
inferred← citeshttps://doi.org/10.1007/s00430-008-0092-3openalex-snapshot
Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy
inferred← citeshttps://doi.org/10.1007/s00430-008-0093-2openalex-snapshot
CD8 T-cell-based immunotherapy of cytomegalovirus infection: “proof of concept” provided by the murine model
inferred← citeshttps://doi.org/10.1007/s00430-012-0256-zopenalex-snapshot
Antigen presentation under the influence of ‘immune evasion’ proteins and its modulation by interferon-gamma: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells
inferred← citeshttps://doi.org/10.1007/s00430-012-0258-xopenalex-snapshot
Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infection
inferred← citeshttps://doi.org/10.1007/s00430-012-0268-8openalex-snapshot
Immune control in the absence of immunodominant epitopes: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells
inferred← citeshttps://doi.org/10.1007/s00430-015-0386-1openalex-snapshot
Mast cells: innate attractors recruiting protective CD8 T cells to sites of cytomegalovirus infection
inferred← citeshttps://doi.org/10.1007/s00430-015-0408-zopenalex-snapshot
Mechanism of tumor remission by cytomegalovirus in a murine lymphoma model: evidence for involvement of virally induced cellular interleukin-15
inferred← citeshttps://doi.org/10.1007/s00430-015-0415-0openalex-snapshot
How understanding immunology contributes to managing CMV disease in immunosuppressed patients: now and in future
inferred← citeshttps://doi.org/10.1007/s00430-016-0471-0openalex-snapshot
Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with ‘humanized’ antigen presentation as a new preclinical study tool
inferred← citeshttps://doi.org/10.1007/s00430-022-00733-wopenalex-snapshot
Cytomegalovirus immune evasion sets the functional avidity threshold for protection by CD8 T cells
inferred← citeshttps://doi.org/10.1007/s10238-009-0037-1openalex-snapshot
Immunomodulation in the treatment of haematological malignancies
inferred← citeshttps://doi.org/10.1007/s10522-016-9642-zopenalex-snapshot
Is immunosenescence influenced by our lifetime “dose” of exercise?
inferred← citeshttps://doi.org/10.1007/s10875-006-9035-1openalex-snapshot
High Frequencies Cytomegalovirus pp65495–503-Specific CD8+ T Cells in Healthy Young and Elderly Chinese Donors: Characterization of Their Phenotypes and TCR Vβ Usage
inferred← citeshttps://doi.org/10.1007/s11357-012-9393-yopenalex-snapshot
Reversing T cell immunosenescence: why, who, and how
inferred← citeshttps://doi.org/10.1007/s11523-012-0207-zopenalex-snapshot
Adoptive transfer with high-affinity TCR to treat human solid tumors: how to improve the feasibility?
inferred← citeshttps://doi.org/10.1007/s11882-017-0669-2openalex-snapshot
Adoptive T Cell Immunotherapy for Patients with Primary Immunodeficiency Disorders
inferred← citeshttps://doi.org/10.1007/s12026-007-0059-2openalex-snapshot
Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants
inferred← citeshttps://doi.org/10.1007/s12026-008-8080-7openalex-snapshot
Shortening the immunodeficient period after hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.1007/s12185-011-0802-2openalex-snapshot
Alemtuzumab for the prevention and treatment of graft-versus-host disease
inferred← citeshttps://doi.org/10.1007/s40778-015-0027-zopenalex-snapshot
T Cell Immunotherapy for Immune Reconstitution and GVHD Prevention After Allogeneic Hematopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1007/s40778-017-0107-3openalex-snapshot
Virus-Specific T Cells for Hematopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1007/s42451-021-00392-wopenalex-snapshot
Allogene virusspezifische T‑Zellen als innovative Therapieoption
inferred← citeshttps://doi.org/10.1016/b978-0-443-06839-3.00307-6openalex-snapshot
Nosocomial Herpesvirus Infections
inferred← citeshttps://doi.org/10.1016/b978-1-4557-4801-3.00308-8openalex-snapshot
Nosocomial Herpesvirus Infections
inferred← citeshttps://doi.org/10.1016/bs.apcsb.2024.02.002openalex-snapshot
MHC tetramer technology: Exploring T cell biology in health and disease
inferred← citeshttps://doi.org/10.1016/j.bbmt.2007.02.004openalex-snapshot
Ex Vivo Expansion and Prophylactic Infusion of CMV-pp65 Peptide-Specific Cytotoxic T-Lymphocytes following Allogeneic Hematopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1016/j.bbmt.2007.10.022openalex-snapshot
T Cell Therapy in Allogeneic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1016/j.bbmt.2009.06.019openalex-snapshot
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
inferred← citeshttps://doi.org/10.1016/j.bbmt.2010.02.007openalex-snapshot
Protective Immunity Transferred by Infusion of Cytomegalovirus-Specific CD8+ T Cells within Donor Grafts: Its Associations with Cytomegalovirus Reactivation Following Unmanipulated Allogeneic Hematopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1016/j.bbmt.2010.12.008openalex-snapshot
Most Closely HLA-Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
inferred← citeshttps://doi.org/10.1016/j.bbmt.2012.01.022openalex-snapshot
Targeting Cytomegalovirus-Infected Cells Using T Cells Armed with Anti-CD3 × Anti-CMV Bispecific Antibody
inferred← citeshttps://doi.org/10.1016/j.bbmt.2012.09.016openalex-snapshot
Enhancing Immune Reconstitution: From Bench to Bedside
inferred← citeshttps://doi.org/10.1016/j.bbmt.2013.01.021openalex-snapshot
Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Be Efficiently Expanded from Granulocyte Colony-Stimulating Factor–Mobilized Hemopoietic Progenitor Cell Products Ex Vivo and Safely Transferred to Stem Cell Transplantation Recipients to Facilitate Immune Reconstitution
inferred← citeshttps://doi.org/10.1016/j.bbmt.2013.07.015openalex-snapshot
CMV-, EBV- and ADV-Specific T Cell Immunity: Screening and Monitoring of Potential Third-Party Donors to Improve Post-Transplantation Outcome
inferred← citeshttps://doi.org/10.1016/j.bbmt.2014.07.018openalex-snapshot
Will Post-Transplantation Cell Therapies for Pediatric Patients Become Standard of Care?
inferred← citeshttps://doi.org/10.1016/j.bbmt.2015.05.015openalex-snapshot
Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia
inferred← citeshttps://doi.org/10.1016/j.bbmt.2017.10.035openalex-snapshot
Cellular Immunotherapy for Hematologic Malignancies: Beyond Bone Marrow Transplantation
inferred← citeshttps://doi.org/10.1016/j.bbrc.2011.06.164openalex-snapshot
A novel system of artificial antigen-presenting cells efficiently stimulates Flu peptide-specific cytotoxic T cells in vitro
inferred← citeshttps://doi.org/10.1016/j.bcmd.2007.07.002openalex-snapshot
CMV-specific T cell therapy
inferred← citeshttps://doi.org/10.1016/j.beha.2011.06.003openalex-snapshot
Adoptive immunotherapy with virus-specific T cells
inferred← citeshttps://doi.org/10.1016/j.cair.2006.06.002openalex-snapshot
Cytomegalovirus and the immune system in old age
inferred← citeshttps://doi.org/10.1016/j.cellimm.2015.12.004openalex-snapshot
Non-cognate bystander cytolysis by clonal epitope-specific CTL lines through CD28–CD80 interaction inhibits antibody production: A potential caveat to CD8 T-cell immunotherapy
inferred← citeshttps://doi.org/10.1016/j.chembiol.2007.07.010openalex-snapshot
Structural Engineering of pMHC Reagents for T Cell Vaccines and Diagnostics
inferred← citeshttps://doi.org/10.1016/j.clim.2013.11.005openalex-snapshot
Elevated granzyme M-expressing lymphocytes during cytomegalovirus latency and reactivation after allogeneic stem cell transplantation
inferred← citeshttps://doi.org/10.1016/j.clim.2019.06.007openalex-snapshot
A novel simplified method of generating cytomegalovirus-specific cytokine-induced killer cells of high specificity and superior potency with GMP compliance
inferred← citeshttps://doi.org/10.1016/j.clim.2020.108456openalex-snapshot
Generation of high-affinity CMV-specific T cells for adoptive immunotherapy using IL-2, IL-15, and IL-21
inferred← citeshttps://doi.org/10.1016/j.coi.2009.02.010openalex-snapshot
Adoptive transfer of virus-specific and tumor-specific T cell immunity
inferred← citeshttps://doi.org/10.1016/j.coi.2009.08.006openalex-snapshot
Pathogen specific T-lymphocytes for the reconstitution of the immunocompromised host
inferred← citeshttps://doi.org/10.1016/j.crvi.2007.04.003openalex-snapshot
La thérapie cellulaire des maladies héréditaires du système hématopoïétique
inferred← citeshttps://doi.org/10.1016/j.ddstr.2006.02.011openalex-snapshot
Adoptive T lymphocyte therapy to fight cytomegalovirus infection in immunodeficient hosts
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2013.11.007openalex-snapshot
Multimer monitoring of CMV-specific T cells in research and in clinical applications
inferred← citeshttps://doi.org/10.1016/j.eimc.2011.05.022openalex-snapshot
GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients
inferred← citeshttps://doi.org/10.1016/j.ejcb.2011.04.001openalex-snapshot
Virus-specific T cells for therapy – Approaches, problems, solutions
inferred← citeshttps://doi.org/10.1016/j.exphem.2005.11.012openalex-snapshot
Human cytomegalovirus infection of cells of hematopoietic origin: HCMV-induced immunosuppression, immune evasion, and latency
inferred← citeshttps://doi.org/10.1016/j.exphem.2007.12.011openalex-snapshot
Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8+ CD62L(high)+ T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rγnull mice
inferred← citeshttps://doi.org/10.1016/j.hoc.2010.11.014openalex-snapshot
Immunotherapy and Vaccination After Transplant: The Present, the Future
inferred← citeshttps://doi.org/10.1016/j.idc.2010.01.004openalex-snapshot
Immunotherapy and Vaccination After Transplant: The Present, the Future
inferred← citeshttps://doi.org/10.1016/j.immuni.2008.07.017openalex-snapshot
Memory Inflation during Chronic Viral Infection Is Maintained by Continuous Production of Short-Lived, Functional T Cells
inferred← citeshttps://doi.org/10.1016/j.immuni.2014.05.018openalex-snapshot
Serial Transfer of Single-Cell-Derived Immunocompetence Reveals Stemness of CD8+ Central Memory T Cells
inferred← citeshttps://doi.org/10.1016/j.jcyt.2012.10.007openalex-snapshot
Optimization of methodology for production of CD25/CD71 allodepleted donor T cells for clinical use
inferred← citeshttps://doi.org/10.1016/j.jcyt.2013.11.010openalex-snapshot
The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care
inferred← citeshttps://doi.org/10.1016/j.jcyt.2014.02.001openalex-snapshot
Immunotherapy: opportunities, risks and future perspectives
inferred← citeshttps://doi.org/10.1016/j.jcyt.2014.02.010openalex-snapshot
The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation—implications for preventative treatment approaches
inferred← citeshttps://doi.org/10.1016/j.jcyt.2014.04.003openalex-snapshot
Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation
inferred← citeshttps://doi.org/10.1016/j.jcyt.2014.05.023openalex-snapshot
Clinical-scale isolation of ‘minimally manipulated’ cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease
inferred← citeshttps://doi.org/10.1016/j.jcyt.2014.12.007openalex-snapshot
Adoptive immunotherapy with the use of regulatory T cells and virus-specific T cells derived from cord blood
inferred← citeshttps://doi.org/10.1016/j.jcyt.2015.03.613openalex-snapshot
Selection of adenovirus-specific and Epstein-Barr virus–specific T cells with major histocompatibility class I streptamers under Good Manufacturing Practice (GMP)–compliant conditions
inferred← citeshttps://doi.org/10.1016/j.jcyt.2017.07.012openalex-snapshot
Cellular therapy for multiple pathogen infections after hematopoietic stem cell transplant
inferred← citeshttps://doi.org/10.1016/j.jcyt.2018.01.008openalex-snapshot
The simultaneous isolation of multiple high and low frequent T-cell populations from donor peripheral blood mononuclear cells using the major histocompatibility complex I-Streptamer isolation technology
inferred← citeshttps://doi.org/10.1016/j.jcyt.2018.05.009openalex-snapshot
Generation of multivirus-specific T cells by a single stimulation of peripheral blood mononuclear cells with a peptide mixture using serum-free medium
inferred← citeshttps://doi.org/10.1016/j.jcyt.2022.05.010openalex-snapshot
Viral infection in hematopoietic stem cell transplantation: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatment
inferred← citeshttps://doi.org/10.1016/j.jfma.2012.02.020openalex-snapshot
Streptamer versus tetramer-based selection of functional cytomegalovirus-specific T cells
inferred← citeshttps://doi.org/10.1016/j.jim.2007.01.001openalex-snapshot
Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens
inferred← citeshttps://doi.org/10.1016/j.jim.2012.01.001openalex-snapshot
Selective binding of CD4 and CD8 T-cells to antigen presenting cells for enrichment of CMV and HIV specific T-lymphocytes
inferred← citeshttps://doi.org/10.1016/j.jim.2013.07.014openalex-snapshot
The abrogation of TCR-independent interactions with human serum ensures a selective capture of therapeutic virus-specific CD8+ T-cells by Multimer Technology in Adoptive Immunotherapy
inferred← citeshttps://doi.org/10.1016/j.jprot.2010.05.009openalex-snapshot
Technologies for MHC class I immunoproteomics
inferred← citeshttps://doi.org/10.1016/j.jtct.2025.10.030openalex-snapshot
Excellent Outcome of 1-Day Nonmyeloablative Salvage Regimen for Pediatric Patients with Graft Failure following Haploidentical Hematopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1016/j.leukres.2015.12.003openalex-snapshot
CD123 redirected multiple virus-specific T cells for acute myeloid leukemia
inferred← citeshttps://doi.org/10.1016/j.mad.2016.06.005openalex-snapshot
Cytomegalovirus driven immunosenescence—An immune phenotype with or without clinical impact?
inferred← citeshttps://doi.org/10.1016/j.molmed.2005.11.006openalex-snapshot
Human cytomegalovirus vaccine: time to look for alternative options
inferred← citeshttps://doi.org/10.1016/j.omtm.2018.12.010openalex-snapshot
In Vitro Expansion of Anti-viral T Cells from Cord Blood by Accelerated Co-cultured Dendritic Cells
inferred← citeshttps://doi.org/10.1016/j.pcl.2006.05.007openalex-snapshot
Recent Molecular and Cellular Advances in Pediatric Bone Marrow Transplantation
inferred← citeshttps://doi.org/10.1016/j.pcl.2009.11.002openalex-snapshot
T-cell-based Therapies for Malignancy and Infection in Childhood
inferred← citeshttps://doi.org/10.1016/j.semarthrit.2024.152396openalex-snapshot
Qualitative evaluation of connective tissue disease with cytomegalovirus infection: A meta-analysis of case reports
inferred← citeshttps://doi.org/10.1016/j.smim.2009.02.004openalex-snapshot
Stem cell-like plasticity of naïve and distinct memory CD8+ T cell subsets
inferred← citeshttps://doi.org/10.1016/j.tim.2020.04.003openalex-snapshot
Role of Neutralizing Antibodies in CMV Infection: Implications for New Therapeutic Approaches
inferred← citeshttps://doi.org/10.1016/j.transci.2010.07.022openalex-snapshot
Targeted cellular immunotherapy for leukemia patients
inferred← citeshttps://doi.org/10.1016/j.transci.2016.05.012openalex-snapshot
Immunoselection techniques in hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.1016/j.transproceed.2010.07.034openalex-snapshot
Wilms' Tumor 1 as a Novel Target for Immunotherapy of Leukemia
inferred← citeshttps://doi.org/10.1016/j.transproceed.2013.04.015openalex-snapshot
Rapid Generation of Epstein-Barr Virus–Specific T Cells for Cellular Therapy
inferred← citeshttps://doi.org/10.1016/j.vaccine.2006.09.067openalex-snapshot
Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1
inferred← citeshttps://doi.org/10.1016/j.virol.2008.04.034openalex-snapshot
A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA vaccine vector
inferred← citeshttps://doi.org/10.1016/j.virusres.2010.09.022openalex-snapshot
In vivo impact of cytomegalovirus evasion of CD8 T-cell immunity: Facts and thoughts based on murine models
inferred← citeshttps://doi.org/10.1016/s0065-2776(07)96003-4openalex-snapshot
The Expansion and Maintenance of Antigen‐Selected CD8+ T Cell Clones
inferred← citeshttps://doi.org/10.1016/s0378-3782(14)70006-4openalex-snapshot
Possible alternatives to antimicrobial therapies
inferred← citeshttps://doi.org/10.1016/s0580-9517(10)37016-4openalex-snapshot
CD8 T-Cell Immunotherapy of Cytomegalovirus Disease in the Murine Model
inferred← citeshttps://doi.org/10.1016/s1773-035x(12)71309-6openalex-snapshot
Apport des méthodes d’isolement immunomagnétique de lymphocytes T cytotoxiques dans la restauration rapide d’une immunité antivirale après allogreffe de cellules souches hématopoïétiques
inferred← citeshttps://doi.org/10.1016/s1773-035x(12)71782-3openalex-snapshot
Traitement par lymphothérapie adoptive des infections virales chez les patients transplantés : de réelles raisons d’espérer
inferred← citeshttps://doi.org/10.1017/9781316335727.063openalex-snapshot
Novel Cell Therapies and Manipulations: Ready for Prime-Time?
inferred← citeshttps://doi.org/10.1017/9781316335727.065openalex-snapshot
Immune Therapy with Cytotoxic T-Lymphocytes for Treatment of Infections
inferred← citeshttps://doi.org/10.1017/cbo9780511545313.075openalex-snapshot
Adoptive immunotherapy for herpesviruses
inferred← citeshttps://doi.org/10.1021/acsnano.5b02829openalex-snapshot
Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy
inferred← citeshttps://doi.org/10.1021/ja9037565openalex-snapshot
Class I Major Histocompatibility Complexes Loaded by a Periodate Trigger
inferred← citeshttps://doi.org/10.1038/bmt.2011.158openalex-snapshot
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
inferred← citeshttps://doi.org/10.1038/bmt.2012.262openalex-snapshot
Viral-specific adoptive immunotherapy after allo-SCT: the role of multimer-based selection strategies
inferred← citeshttps://doi.org/10.1038/bmt.2013.114openalex-snapshot
Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis
inferred← citeshttps://doi.org/10.1038/bmt.2015.97openalex-snapshot
Umbilical cord blood graft engineering: challenges and opportunities
inferred← citeshttps://doi.org/10.1038/bmt.2016.17openalex-snapshot
Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections
inferred← citeshttps://doi.org/10.1038/bmt.2017.232openalex-snapshot
Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT
inferred← citeshttps://doi.org/10.1038/cr.2016.153openalex-snapshot
Immunotherapy against cancer-related viruses
inferred← citeshttps://doi.org/10.1038/cti.2014.2openalex-snapshot
Accelerating immune reconstitution after hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.1038/gt.2010.4openalex-snapshot
Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer
inferred← citeshttps://doi.org/10.1038/icb.2010.136openalex-snapshot
Understanding human T‐cell‐mediated immunoregulation through herpesviruses
inferred← citeshttps://doi.org/10.1038/icb.2010.20openalex-snapshot
Cross‐presentation of HCMV chimeric protein enables generation and measurement of polyclonal T cells
inferred← citeshttps://doi.org/10.1038/leu.2013.378openalex-snapshot
Hunting for clinical translation with innate-like immune cells and their receptors
inferred← citeshttps://doi.org/10.1038/leu.2017.16openalex-snapshot
Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT
inferred← citeshttps://doi.org/10.1038/mt.2009.140openalex-snapshot
Nucleofection of DCs to Generate Multivirus-specific T Cells for Prevention or Treatment of Viral Infections in the Immunocompromised Host
inferred← citeshttps://doi.org/10.1038/mt.2012.130openalex-snapshot
Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections
inferred← citeshttps://doi.org/10.1038/mt.2013.151openalex-snapshot
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant
inferred← citeshttps://doi.org/10.1038/mtna.2012.49openalex-snapshot
Moving Successful Virus-specific T-cell Therapy for Hematopoietic Stem Cell Recipients to Late Phase Clinical Trials
inferred← citeshttps://doi.org/10.1038/nm1360openalex-snapshot
Design and use of conditional MHC class I ligands
inferred← citeshttps://doi.org/10.1038/nm1475openalex-snapshot
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals
inferred← citeshttps://doi.org/10.1038/nprot.2006.121openalex-snapshot
Generation of peptide–MHC class I complexes through UV-mediated ligand exchange
inferred← citeshttps://doi.org/10.1038/nrclinonc.2012.111openalex-snapshot
T-cell therapy in the treatment of post-transplant lymphoproliferative disease
inferred← citeshttps://doi.org/10.1038/nri3020openalex-snapshot
Interrogating the repertoire: broadening the scope of peptide–MHC multimer analysis
inferred← citeshttps://doi.org/10.1038/s41375-019-0600-zopenalex-snapshot
Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation—a phase I/II study
inferred← citeshttps://doi.org/10.1038/s41423-021-00829-yopenalex-snapshot
Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantation
inferred← citeshttps://doi.org/10.1038/s41467-024-54595-2openalex-snapshot
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years
inferred← citeshttps://doi.org/10.1038/s41467-025-60394-0openalex-snapshot
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence
inferred← citeshttps://doi.org/10.1038/s41551-017-0143-4openalex-snapshot
Determining T-cell specificity to understand and treat disease
inferred← citeshttps://doi.org/10.1038/s41551-019-0409-0openalex-snapshot
Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function
inferred← citeshttps://doi.org/10.1038/s41587-019-0017-2openalex-snapshot
An injectable bone marrow–like scaffold enhances T cell immunity after hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.1038/s42003-021-02709-7openalex-snapshot
Features of repertoire diversity and gene expression in human cytotoxic T cells following allogeneic hematopoietic cell transplantation
inferred← citeshttps://doi.org/10.1038/s43018-019-0004-zopenalex-snapshot
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation
inferred← citeshttps://doi.org/10.1038/sj.bmt.1705667openalex-snapshot
T cell therapies following hematopoietic stem cell transplantation: surely there must be a better way than DLI?
inferred← citeshttps://doi.org/10.1038/sj.bmt.1705906openalex-snapshot
Adoptive cellular immunotherapy for viral diseases
inferred← citeshttps://doi.org/10.1038/sj.bmt.1705932openalex-snapshot
Functional analysis of cytomegalovirus-specific T lymphocytes compared to tetramer assay in patients undergoing hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.1038/sj.mt.6300216openalex-snapshot
Monoclonal T-Cell Receptors: New Reagents for Cancer Therapy
inferred← citeshttps://doi.org/10.1038/srep04166openalex-snapshot
Building and Optimizing a Virus-specific T Cell Receptor Library for Targeted Immunotherapy in Viral Infections
inferred← citeshttps://doi.org/10.1055/s-0032-1328112openalex-snapshot
Peptidselektive Isolierung unmanipulierter T-Zellen für die adoptive Immuntherapie
inferred← citeshttps://doi.org/10.1055/s-0033-1333749openalex-snapshot
Adoptive T-cell Transfer for Refractory Viral Infections with Cytomegalovirus, Epstein-Barr Virus or Adenovirus after Allogeneic Stem Cell Transplantation
showing the first 200 of 463 · page through all 463
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.